Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2288965생성일: 2026년 10월 25일
2,2,2-Trifluoroethanol → 1-(4-[5-(4-Fluoro-phenyl)-4-(2,2,2-trifluoro-ethoxymethyl)-oxazol-2-yl]-piperidin-1-yl)-ethanone
https://huagongshe.com/reaction/2288965
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 2,2,2-Trifluoroethanol | HCID 6409 | — |
| 반응물 | Sodium hydride | HCID 24758 | — |
| 반응물 | Iodide Ion | HCID 30165 | — |
| 반응물 | Diisopropylethylamine | HCID 81531 | — |
| 반응물 | Methanesulfonic anhydride | HCID 81560 | — |
| 반응물 | Methanesulfonate | HCID 85257 | — |
| 반응물 | Sodium | HCID 5360545 | — |
| 반응물 | 1-(4-[5-(4-Fluoro-phenyl)-4-hydroxymethyl-oxazol-2-yl]-piperidin-1-yl)-ethanone | HCID 18700463 | — |
| 반응물 | Ethanol, 2,2,2-trifluoro-, sodium salt (1:1) | HCID 23677971 | — |
| 용매 | Diethyl Ether | HCID 3283 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 생성물 | 1-(4-[5-(4-Fluoro-phenyl)-4-(2,2,2-trifluoro-ethoxymethyl)-oxazol-2-yl]-piperidin-1-yl)-ethanone | HCID 18700469 | — |
반응 단계
To a stirred mixture of 18.85 g (59.2 mmol) 1-(4-[5-(4-fluoro-phenyl)-4-hydroxymethyl-oxazol-2-yl]-piperidin-1-yl)-ethanone, prepared as in Part C, and 11.5 g (66.0 mmol) methanesulfonic anhydride in 300 ml anhydrous tetrahydrofuran, 13.06 ml (75 mmol) N,N-diisopropylethylamine is added at 10° C. over 20 minutes. The mixture is allowed to warm to 20° C. and stirred for 90 minutes at 20° C. When the mesylate formation is complete as monitored by 1H-NMR, 15 g (100 mmol) of solid sodium lodide is added. The conversion of the mesylate to the iodide is complete (as monitored by 1H-NMR) in about 2 hr. A solution of sodium 2,2,2-trifluoroethoxide, made from 21.8 ml (300 ml) 2,2,2-trifluoroethanol, 12 g (300 mmol) sodium hydride (60% disp. in mineral oil) in 280 ml anhydrous tetrahydrofuran, is added to reaction mixture. The resulting slurry is stirred at room temperature for 60 minutes, diluted with 500 mL ether, and extracted with water (3×200 mL). The water phase is extracted with methylene chloride (2×200 mL), and the organic phases are combined, dried with anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue is then transferred to a silica gel packed column and purified using the following solvent mixtures: hexane-ethyl acetate (1:1), ethyl acetate (neat) then ethyl acetate-ethanol (9:1) to yield the title compound. 1H-NMR (CDCl3) d 1.88 (m, 2H), 2.10-2.20 (m, 2H), 2.16 (d, 3H), 2.91 (t, 1H), 3.12 (m, 1H), 3.28 (t, 1H), 3.93 (d, 1H), 4.00 (q, 2H), 4.57 (d, 1H), 4.71 (s, 2H), 7.19 (t, 2H), 7.65 (dd, 2H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06090825 |
|---|
| 출처 데이터셋 | uspto-grants-2000_07 |
|---|
| ORD ID | ord-480663b6f5104a2297f489c2575c30cc |
|---|
| 출처 메모 | uspto-grants-2000_07 |
|---|